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Abstract
microRNAs (miRNAs) are small, non-coding RNAs that have been shown to play a critical role in 
normal physiology and disease, such as hematopoietic development and cancer. However, their 
role in mast cell function and development is poorly understood. The major objective of this study 
was to determine how global miRNA expression affects mast cell physiology. The RNase III 
endonuclease, Dicer, is required for the processing of pre-miRNAs into mature miRNAs. To 
investigate the effect of global miRNA depletion on mast cells in vivo, we generated a mast cell-
specific knock out of Dicer in mice. Transgenic mice (Mcpt5-Cre) that express Cre selectively in 
connective tissue mast cells were crossed with mice carrying the floxed conditional Dicer allele 
(Dicer fl/fl). Mcpt5-Cre x Dicer fl/fl mice with homozygous Dicer gene deletion in mast cells were 
found to have a profound mast cell deficiency with near complete loss of peritoneal, 
gastrointestinal, and skin mast cells. We examined the in vivo functional consequence of mast 
cell-specific Dicer deletion using an IgE-dependent passive systemic anaphylaxis (PSA) murine 
model. IgE sensitized wild type Mcpt5-Cre x Dicer +/+ and heterozygous Mcpt5-Cre x Dicer fl/+ 
mice show marked hypothermia with antigen; however, homozygous Mcpt5-Cre x Dicer fl/fl mice 
were completely unresponsive to antigen challenge. These studies suggest a critical role for Dicer 
and miRNA expression for establishment of tissue compartments of functional mast cells in vivo.
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Introduction
Mast cells are critical effectors of allergic and inflammatory responses [1]. They also 
participate in normal innate immune responses to bacteria and parasites [2]. Dysregulated 
proliferation of mast cells manifest in diseases that range from benign cutaneous 
mastocytosis to mast cell leukemia [3]. They are derived from hematopoietic stem cells in 
the bone marrow, but they migrate and reside in the connective tissue of skin, lung, and 
gastrointestinal tract mucosa. Normal mast cell development is dependent on a network of 
transcription factors [4] which coordinate the expression of critical gene targets. The role of 
epigenetic regulators of gene expression in mast cells, such as miRNAs, has not been 
extensively studied.
miRNAs are small, non-coding RNA nucleotides, about 18 to 24 base pairs in size, and are 
expressed in a tissue-specific and developmentally-regulated fashion. They function 
primarily as negative regulators of protein expression. The RNase III endonuclease, Dicer, is 
necessary for mature, double-stranded miRNAs. Inhibition of Dicer by RNAi or gene 
targeting results in global depletion of miRNA expression [5,6]. miRNA profiling 
experiments have identified the expression pattern of miRNAs in bone marrow derived mast 
cells (BMMC) during development [7,8]. Our group previously identified the miR-381 and 
miR-539 cluster that regulates Mitf expression in response to c-Kit signaling [9]. Other 
investigators have shown roles for miRNAs in cell cycle regulation and proliferation, as well 
as apoptosis and degranulation [10–13]. Global depletion of miRNAs through deletion of 
Dicer function has been demonstrated to have critical roles in normal differentiation and 
function of myeloid cells such as neutrophils, macrophages, and dendritic cells [14–16]. The 
role of global depletion of miRNA in mast cells is yet unexplored. In order to address this 
question, we generated mice with a mast cell-selective deletion of Dicer by crossing the 
Mcpt5-Cre strain with Dicer fl/fl strain and found a profound loss of tissue mast cells. These 
studies demonstrate a critical role for miRNA expression in mast cell development.
Materials and Methods
Animals
Mcpt5-Cre mice were kindly provided by Dr. Axel Roers from Dresden, Germany [17]. 
These mice harbor a transgene in which the coding region of the first exon of the Mcpt5 
gene is replaced with a Cre-encoding cDNA; Cre is expressed in the connective tissue mast 
cells of skin and peritoneum [17,18]. Dicer fl/fl mice were obtained from the Jackson 
Laboratory (Bar Harbor ME) and previously described [5]. These two strains are on the 
C57BL/6 background. Six to 12 week old Mcpt5-Cre x Dicer fl/fl mice were used to obtain 
splenocytes and bone marrow and were also used for the anaphylaxis experiments. Mice 
were maintained in the Johns Hopkins University Animal Facilities in strict accordance with 
institutional guidelines. All experiments were approved by the Johns Hopkins University 
Animal Care and Use Committee.
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Passive systemic anaphylaxis (PSA) and active systemic anaphylaxis (ASA)
The passive and active systemic anaphylaxis experiments were previously described [19]. 
For passive systemic anaphylaxis, mice were given 10 ug of anti-DNP IgE and were 
challenged 24 hours later with 1 mg of DNP-HAS antigen (Sigma-Aldrich, St Louis) 
intravenously. For active systemic anaphylaxis, mice were immunized by intraperitoneal 
injection of 50 mcg OVA mixed with 1 mg Alum and challenged 2 weeks later by 1 mg 
OVA intravenously. For both passive and active anaphylaxis models, body temperature and 
clinical scores, including survival were recorded every 10 minutes up to 90 minutes after 
challenge. The t-test was used for analysis of body temperature change and clinical scores. 
The log-rank (Mantel-Cox) test (chi-square) was used for survival analysis. At the 
completion of the passive and active anaphylaxis experiments, mice were euthanized with a 
combination of Ketamine/Xylazine (400 mg/40 mg/kg) given intraperitoneally.
Quantification of tissue mast cells
Indicated tissues from mice of different genotypes were harvested and fixed in 10% buffered 
formalin, sectioned and stained with 0.5% toluidine blue (Sigma Aldrich, St. Louis, MO). 
For each sample, mast cells, as identified by the presence of metachromatic granules stained 
by toluidine blue. 5 to 10 fields were counted under 50X magnification. Average numbers of 
mast cells in a given field are represented. For identification of mast cells in the peritoneal 
cavity, peritoneal fluid was obtained by lavage, cytospined, and stained with Wright giemsa. 
Total cells and mast cell percentage were determined by counting cells from 5 to 10 fields 
under 50X magnification.
Results and Discussion
Mast cell-specific deletion of Dicer results in loss of tissue mast cells
Mice with homozygous mast cell deletion of Dicer (Mcpt5-Cre/Dicer fl/fl, herein referred to 
as MC-Dicer −/−) and heterozygous deletion of Dicer (MC-Dicer +/−) were viable and 
healthy and indistinguishable from wild type (Mcpt5-Cre/Dicer +/+) mice. However, there 
was a striking reduction of peritoneal mast cells in MC-Dicer −/− mice compared to wild 
type mice. In addition, mast cells in the skin and submucosa of stomach were profoundly 
reduced compared to tissues of wild type mice (Figure 1). Other tissues, including lung, 
small intestine, submucosa of stomach, and colon, were also examined. These tissues had 
almost no detectable mast cells by toluidine blue staining from both wild type and MC-Dicer 
−/− mice (data not shown). The expression of Cre in the Mcpt5-Cre mice is restricted to 
mast cells; other hematopoietic cell types, including basophils, are not affected 
(supplementary data).
MC-Dicer −/− mice are resistant to anaphylaxis
We examined the in vivo functional consequence of mast cell-specific Dicer deletion using 
an ovalbumin (OVA) allergen induced active systemic anaphylaxis (ASA) murine model 
[19]. As shown in Figures 2A and 2B, WT mice showed clear anaphylactic responses 
including significant drop in body temperature, severe clinical symptoms and death. 
However, MC-Dicer −/− mice showed only mild changes in body temperature, mild clinical 
symptoms, and no death. Five of 10 control WT mice did not survive to completion of the 
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experiment compared to 0 of 7 MC-Dicer −/− mice (p=0.034). There was also a statistically 
significance difference in clinical symptoms (score 3.7 in WT versus 1.0 in MC-Dicer −/−, 
p=0.0003).
We also examined mast cell-specific Dicer deletion in the passive systemic anaphylaxis 
(PSA) murine model which is dependent on mast cells [19,20]. As shown in Figure 2C, IgE 
sensitized WT mice showed symptoms of anaphylaxis as evidenced by marked hypothermia 
with antigen; however, MC-Dicer −/− mice were completely protected against systemic 
anaphylaxis. These results indicate that in the absence of Dicer function and mast cells do 
not mature normally; mast cell-dependent allergic responses require connective tissue mast 
cells rather than mucosal mast cells. The mild responses of MC-Dicer −/− mice in the ASA 
model may be mediated by basophils and macrophages, which would not be expected to be 
affected in the Mcpt5-Cre model [21].
Taken together, these studies suggest a critical role for Dicer and miRNA expression for 
establishment of tissue compartments of connective tissue mast cells in vivo. In our model, 
Dicer is deleted in committed mast cell precursors, with expression of the protease, Mcpt-5. 
The absence of connective tissue mast cells may be due to the requirement for Dicer in 
differentiation, migration, survival, or proliferation. However, this central question of how 
Dicer and microRNAs regulate the population of tissue mast cell compartments is yet to be 
addressed.
A challenge to further examining the mechanism of Dicer deletion on mast cell function and 
development is the lack of tissue mast cells to study in our in vivo model. BMMCs are a 
useful tool to examine mast cell differentiation and function ex vivo. However, because of 
low expression of Cre, BMMCs from these MC-Dicer −/− mice are not a suitable model 
system to examine Dicer function [17,22]. In BMMCs from MC-Dicer −/− mice, we found 
incomplete deletion of Dicer; and no discernable phenotypic differences in granule 
expression by toluidine blue stain and c-KIT/FcεRIα expression compared to WT BMMCs 
(supplementary data). We found that MC-Dicer −/+ mice have no significant differences in 
tissue mast cell populations and susceptibility to active or systemic anaphylaxis, suggesting 
that subphysiologic expression of Dicer is sufficient for normal mast cell development. 
Further studies of the mechanisms of Dicer function in mast cells will be aided by other 
approaches, such as inducible systems to delete Dicer in vivo and ex vivo.
In hematopoietic stem cells, Dicer has been shown to regulate the stem cell and progenitor 
cell pool; conditional deletion of Dicer results in increased apoptosis of this compartment 
[23]. In committed hematopoietic cells, loss of Dicer affects different physiologic functions. 
Dicer deletion in early myeloid progenitors (using a Cre driven by C/EBPA) results in 
severe reduction of macrophages and dysplastic neutrophils [14]. Using a different model 
with a Lyz2-Cre strain, Dicer deletion resulted in an increase in giant cell formation of 
macrophages [16]. In both T and B- lymphocytes, Dicer deletion can result in aberrations in 
differentiation or activation, depending the cell type and stage of development in which 
Dicer function is inhibited [24]. In our study, loss of Dicer function in committed mast cell 
progenitors results in profound loss of tissue mast cell compartments, suggesting a critical 
role for miRNAs in mast cell differentiation, growth or migration. Further studies are needed 
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to determine the essential miRNAs that mediate these functions and their potential impact on 
allergic and inflammatory diseases.
Supplementary Data. Incomplete deletion of Dicer in MC-Dicer −/− BMMC A) PCR from 
BMMC from wild type (Mcpt5-Cre x Dicer +/+) and MC-Dicer −/− (Mcpt5-Cre x Dicer 
fl/fl) is shown. Wild type allele denoted by * and floxed allele denoted by **. The deleted 
allele is shown with arrow. PCR from BMMC from two Dicer +/+ and two Dicer fl/fl mice 
shown. Incomplete deletion noted by the presence of floxed, and undeleted allele **. 
Cytokines for culture condition shown on left. B) BMMCs from MC-Dicer −/− mice show 
no difference in differentiation by co-expression of FcεRIα and c-Kit compared to wild type. 
C) Basophils cultured from MC-Dicer −/− mice show no difference in differentiation by co-
expression of FcεRIα and CD49b compared to wild type. Two independent experiments 
shown for BMMC and basophil cultures.
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Figure 1. 
Loss of tissue mast cells in mice with mast cell-specific deletion of Dicer. A) Tissue sections 
of stomach (submucosa), skin and peritoneum demonstrate near absence of mast cells in 
MC-Dicer −/− tissue. Mast cells denoted by red arrows. Stomach and skin mast cells stained 
with Toluidine blue and peritoneal mast cells stained with Wright Geimsa. Magnification 
50x with insert 100X. B) Quantitation of mast cells in tissue sections demonstrating 
significant reduction in MC-Dicer −/− tissue compared to wild type tissue. Average numbers 
of mast cells per high power field are plotted for skin and stomach. Peritoneal mast cell 
numbers per total number of peritoneal cells are plotted.
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Figure 2. 
Mast cell deletion of Dicer protects against anaphylaxis. A) MC-Dicer −/− mice are 
protected against active systemic anaphylaxis. MC-Dicer −/− show blunted drop in body 
temperature after challenge with antigen compared to wild type mice. WT (n=10); MC-
Dicer −/− (n=7). B) Increased survival of MC-Dicer −/− mice in active systemic anaphylaxis 
model. Half of wild type mice do not survive after antigen challenge, while all MC-Dicer −/
− mice survive. C) MC-Dicer −/− mice are resistant to passive systemic anaphylaxis. MC-
Dicer −/− show no drop in body temperature with antigen challenge, while wild type mice 
show significant decrease in body temperature. WT (n=4); MC-Dicer −/− (n=3).
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